Literature DB >> 34232917

Downregulation of LINC00665 suppresses the progression of lung adenocarcinoma via regulating miR-181c-5p/ZIC2 axis.

Wei Wei1, Xiaoliang Zhao1, Jiang Liu2, Zhenfa Zhang1.   

Abstract

Long non-coding RNA (lncRNA) LINC00665 was demonstrated to be upregulated in lung adenocarcinoma (LUAD) and target miR-181c-5p. ZIC2, which is upregulated in LUAD, serves as a putative target of miR-181c-5p. In this study, we aimed to reveal whether LINC00665 regulates miR-181c-5p/ZIC2 axis to promote LUAD progression. The results showed that LINC00665, HOXA1, ZIC2, and HOXA11 levels were increased in LUAD tissues, while miR-181c-5p level was decreased when compared to the adjacent normal tissues. High expression levels of LINC00665, ZIC2, HOXA1 and HOXA11, and low expression of miR-181c-5p were closely linked to poor prognosis of LUAD patients. Knockdown of LINC00665 induced obvious inhibitions in cell viability, clone formation, invasion and tumorigenesis in LUAD cells, whereas miR-181c-5p downregulation significantly neutralized these effects. In addition, downregulation of ZIC2 obviously reversed the enhancements of cell viability, clone formation, invasion and tumorigenesis induced by miR-181c-5p knockdown. In summary, the present study reveals that silencing of LINC00665 suppresses LUAD progression through targeting miR-181c-5p/ZIC2 axis.

Entities:  

Keywords:  HOXA1; HOXA11; LINC00665; ZIC2; miR-181c-5p

Year:  2021        PMID: 34232917     DOI: 10.18632/aging.203240

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  7 in total

1.  Correlation with Spectral CT Imaging Parameters and Occult Lymph Nodes Metastases in Sufferers with Isolated Lung Adenocarcinoma.

Authors:  Ye Liu; Yongkang Nie
Journal:  Contrast Media Mol Imaging       Date:  2022-06-25       Impact factor: 3.009

Review 2.  The Biological and Molecular Function of LINC00665 in Human Cancers.

Authors:  Cheng Zhang; Shu-Ning Xu; Ke Li; Jing-Hong Chen; Qun Li; Ying Liu
Journal:  Front Oncol       Date:  2022-05-19       Impact factor: 5.738

Review 3.  LINC00665: An Emerging Biomarker for Cancer Diagnostics and Therapeutics.

Authors:  Chenming Zhong; Zijun Xie; Jinze Shen; Yunhua Jia; Shiwei Duan
Journal:  Cells       Date:  2022-05-04       Impact factor: 7.666

4.  Homeobox A1 Facilitates Immune Escape and Alleviates Oxidative Stress in Lung Adenocarcinoma.

Authors:  Fen Zhao; Hui Tian; Xinchao Liu; Yuanxiazi Guan; Ying Zhu; Peng Ren; Jianbo Zhang; Yinjun Dong; Lei Fu
Journal:  Oxid Med Cell Longev       Date:  2022-05-19       Impact factor: 7.310

Review 5.  The Emerging Roles of LINC00665 in Human Cancers.

Authors:  Jing Zhu; Yirao Zhang; Xuyu Chen; Yibo Bian; Juan Li; Keming Wang
Journal:  Front Cell Dev Biol       Date:  2022-03-09

6.  LINC00665 knockdown confers sensitivity in irradiated non-small cell lung cancer cells through the miR-582-5p/UCHL3/AhR axis.

Authors:  Li-Ming Xu; Ya-Jing Yuan; Hao Yu; Shuai Wang; Ping Wang
Journal:  J Transl Med       Date:  2022-08-02       Impact factor: 8.440

7.  LINC00665/miRNAs axis-mediated collagen type XI alpha 1 correlates with immune infiltration and malignant phenotypes in lung adenocarcinoma.

Authors:  Jun Zhu; Yuan Weng; Fudong Wang; Jun Zhao
Journal:  Open Med (Wars)       Date:  2022-07-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.